2
Urine Drug Screening Device Better information. Better decisions. Buprenorphine screening combined with low-level opiate cutoff makes it ideal for clinical settings For in vitro diagnostic use only. Alere iCup ® Dx 14 The original 14 panel CLIA-waived drug test cup.

The original 14 panel CLIA-waived drug test cup. Alere ...repconnectdocuments.s3.amazonaws.com/.../iCup_Dx_14...Alere iCup® Dx 14 Urine Drug Screen Products 800.340.4029 | aleretoxicology.com

  • Upload
    others

  • View
    22

  • Download
    2

Embed Size (px)

Citation preview

Urine Drug Screening Device

Better information. Better decisions.

Buprenorphine screening combined with low-level opiate cutoff makes

it ideal for clinical settings

For in vitro diagnostic use only.

Alere iCup® Dx 14The original 14 panel CLIA-waived drug test cup.

© 2014 Alere. All rights reserved. The Alere Logo, Alere, and iCup are trademarks of the Alere group of companies. 89085 REV1 10/14

Alere iCup® Dx 14 Urine Drug Screen

Products 800.340.4029 | aleretoxicology.com

nn Integrated urine test cup targets 14 illicit and prescription drugs

nn Simple procedure: collect specimen, tilt cup, and read results in five minutes

nn Specimen validity test combinations available: BL, CR, NI, PH, SG*

nn Self-contained cup is ideal for sending presumptive positive specimens for confirmation

nn CLIA-waived

nn Patented cup design

Features & benefits

How it works

Interpret results at 5 minutes.

Tilt the cup on its side to activate test.

Collect specimen and secure the test lid.

1 2 3

C

T1

T2

Negative Presumptive Positive Invalid

C

T1

T2

C

T1

T2

Item No. Drug Configurations Quantity Per Box

I-DX-1147-022 Alere iCup® Dx 14 AMP500, BAR300, BUPG10, BZO300, COC150, MDMA500, MET500, MOP300, MTD300, OXY100, PCP25, PPX300, THC50, TCA1000

25 Tests

I-DXA-2147-011 Alere iCup® Dx 14 SVT with Specimen Validity Test AMP500, BAR300, BUPG10, BZO300, COC150, MDMA500, MET500, MOP300, MTD300, OXY100, PCP25, PPX300, THC50, TCA1000 (BL, CR, NI, pH, SG)

25 Tests

Drug Test Configuration and Cutoff Levels

Drug tests: Amphetamine (AMP), Barbiturates (BAR), Benzodiazepines (BZO), Buprenorphine (BUPG), Cocaine (COC), Marijuana (THC), Methadone (MTD), Methamphetamine (MET), Methylenedioxymethamphetamine (MDMA) Ecstasy, Opiate (MOP300), Oxycodone (OXY), Phencyclidine (PCP), Propoxyphene (PPX), Tricyclic Antidepressants (TCA). *Specimen validity tests: Bleach (BL), Creatinine (CR), Nitrate (NI), pH (pH), Specific Gravity (SG).

PRODUCT PROCEDURE NOTE: Refer to product insert for complete instructions, limitations, and warnings. For professional in vitro diagnostic use only. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.

5min